Carter-Wallace, Inc.
Country not established
- Devices
- 1
What Carter-Wallace, Inc. makes
Carter-Wallace, Inc. manufactures the Wampole HS-CRP ELISA, a diagnostic test used for measuring high-sensitivity C-reactive protein levels in blood samples to assess inflammation or infection risk.
The company’s portfolio is regulated under FDA’s Class II device classification, with the Wampole HS-CRP ELISA authorised via the 510(k) pathway. The device is listed in the FDA’s 510(k) database. The manufacturer is based in the United States.
Catalogue
Wampole Hs-Crp Elisa Ref K011855
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Carter-Wallace, Inc. have in the registry?
The registry currently lists 1 device for Carter-Wallace, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Carter-Wallace, Inc.'s devices?
Among its 1 most recently registered device, Carter-Wallace, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Carter-Wallace, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Carter-Wallace, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Carter-Wallace, Inc. in the registry?
The most recently registered devices listed for Carter-Wallace, Inc. include WAMPOLE HS-CRP ELISA.